US20160089531A1 - Electrode lead including a deployable tissue anchor - Google Patents

Electrode lead including a deployable tissue anchor Download PDF

Info

Publication number
US20160089531A1
US20160089531A1 US14/947,502 US201514947502A US2016089531A1 US 20160089531 A1 US20160089531 A1 US 20160089531A1 US 201514947502 A US201514947502 A US 201514947502A US 2016089531 A1 US2016089531 A1 US 2016089531A1
Authority
US
United States
Prior art keywords
rotatable member
lead body
deployable
central axis
deployable member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/947,502
Inventor
Matthew S. Finlay
William J. Rissmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Corp
Boston Scientific Scimed Inc
Original Assignee
Astora Womens Health LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US14/947,502 priority Critical patent/US20160089531A1/en
Application filed by Astora Womens Health LLC filed Critical Astora Womens Health LLC
Assigned to AMS RESEARCH, LLC reassignment AMS RESEARCH, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AMS RESEARCH CORPATION
Assigned to AMS RESEARCH, LLC reassignment AMS RESEARCH, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: AMS RESEARCH CORPORATION
Assigned to APHRODITE WOMEN'S HEALTH, LLC reassignment APHRODITE WOMEN'S HEALTH, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMS RESEARCH, LLC
Assigned to ASTORA WOMEN'S HEALTH, LLC reassignment ASTORA WOMEN'S HEALTH, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: APHRODITE WOMEN'S HEALTH, LLC
Publication of US20160089531A1 publication Critical patent/US20160089531A1/en
Assigned to WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE reassignment WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASTORA WOMEN'S HEALTH, LLC
Assigned to BOSTON SCIENTIFIC CORPORATION reassignment BOSTON SCIENTIFIC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASTORA WOMEN'S HEALTH HOLDINGS, LLC, ASTORA WOMEN'S HEALTH, LLC, ENDO HEALTH SOLUTIONS INC.
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC CORPORATION
Assigned to AMS RESEARCH CORPORATION reassignment AMS RESEARCH CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FINLAY, MATTHEW S., RISSMANN, WILLIAM J.
Assigned to ENDO PHARMACEUTICALS INC., DAVA INTERNATIONAL, LLC, BIOSPECIFICS TECHNOLOGIES LLC, ACTIENT PHARMACEUTICALS LLC, ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.), DAVA PHARMACEUTICALS, LLC, ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.), ASTORA WOMEN’S HEALTH HOLDINGS, LLC, AUXILIUM PHARMACEUTICALS, LLC, VINTAGE PHARMACEUTICALS, LLC, PAR PHARMACEUTICAL, INC., AUXILIUM US HOLDINGS, LLC, BIOSPECIFICS TECHNOLOGIES CORP., SLATE PHARMACEUTICALS, LLC, GENERICS BIDCO I, LLC, PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC), QUARTZ SPECIALTY PHARMACEUTICALS, LLC, GENERICS INTERNATIONAL (US), INC., ASTORA WOMEN’S HEALTH LLC reassignment ENDO PHARMACEUTICALS INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: WILMINGTON TRUST, NATIONAL ASSOCIATION
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • A61N1/0558Anchoring or fixation means therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/057Anchoring means; Means for fixing the head inside the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0587Epicardial electrode systems; Endocardial electrodes piercing the pericardium
    • A61N1/059Anchoring means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0507Electrodes for the digestive system
    • A61N1/0512Anal electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0507Electrodes for the digestive system
    • A61N1/0514Electrodes for the urinary tract
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/057Anchoring means; Means for fixing the head inside the heart
    • A61N2001/058Fixing tools

Definitions

  • Embodiments of the present invention generally relate to an anchor that facilitates securing devices or components to internal tissue of a patient and preventing migration of the devices or components from their intended location relative to the tissue of the patient.
  • Implantable electronic stimulator devices such as neuromuscular stimulation devices, have been disclosed for use in the treatment of various pelvic conditions, such as urinary incontinence, fecal incontinence and sexual dysfunction.
  • Such devices generally include one or more electrodes that are coupled to a control unit by electrode leads. Electrical signals are applied to the desired pelvic tissue of the patient through the electrode leads in order to treat the condition of the patient.
  • Exemplary implantable electronic stimulator devices and uses of the devices are disclosed in U.S. Pat. Nos. 6,354,991, 6,652,449, 6,712,772 and 6,862,480, each of which is hereby incorporated by reference in its entirety.
  • Anchors to secure the one or more electrodes in tissue of the patient.
  • exemplary anchors include helical coils and mesh, such as that disclosed in (A92.12-0136), which is incorporated herein by reference in its entirety. It is desirable, for example, that such anchors prevent relative movement between the anchor and the tissue in which the anchor in embedded, are easy to install in the tissue, avoid damaging the tissue during the implantation procedure, can be removed without significantly damaging the tissue, and/or have other features or benefits recognized by those skilled in the art.
  • Embodiments of the invention are directed to an implantable electrode lead.
  • the electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism.
  • the rotatable member is contained within a distal end of the tubular lead body.
  • the deployable member is attached to the rotatable member and comprises a tissue anchor.
  • the deployment mechanism is configured to drive the deployable member along a central axis and out the distal end of the tubular lead body responsive to rotation of the rotatable member about the central axis.
  • the deployable member does not rotate about the central axis with the rotation of the rotatable member.
  • the electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism.
  • the rotatable member is contained within a distal end of the tubular lead body.
  • the deployable member is attached to the rotatable member and comprises a tissue anchor.
  • the distal end of the tubular lead body is positioned proximate target tissue of a patient.
  • the rotatable member is rotated relative to the tubular lead body.
  • the deployable member is driven along the central axis, out the distal end of the tubular lead body, and into the target tissue using the deployment mechanism responsive to the rotation of the rotatable member.
  • the deployable member does not rotate about the central axis with the rotation of the rotatable member.
  • FIG. 1 is a side plan view of an exemplary electronic stimulator device, in accordance with embodiments of the invention.
  • FIGS. 2 and 3 are simplified views of an electrode lead formed in accordance with embodiments of the invention positioned within tissue of a patient.
  • FIG. 4 is a simplified side view of a distal end of an electrode lead having a mesh anchor in a deployed position, in accordance with embodiments of the invention.
  • FIG. 5 is a cross-sectional view of the portion of the lead of FIG. 4 taken generally along line 5 - 5 .
  • FIG. 6 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention.
  • FIG. 7 is a cross-sectional view of the electrode lead of FIG. 6 taken generally along line 7 - 7 .
  • FIG. 8 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention.
  • FIG. 9 is a flowchart illustrating a method of using the electrode lead formed in accordance with one or more embodiments of the invention.
  • FIG. 1 is a side plan view of an exemplary electronic stimulator device 100 , in accordance with embodiments of the invention.
  • the stimulator device 100 is configured for implantation into a pelvic region of a patient to provide muscle and/or nerve stimulation that is used to control and/or treat a pelvic condition of the patient, such as pelvic pain, urinary incontinence, fecal incontinence, erectile dysfunction or other pelvic condition that may be treated through electrical stimulation.
  • the device 100 comprises a control unit 102 and one or more electrode leads 104 , a proximal end 106 of which is electrically coupled to the control unit 102 via a connector 108 .
  • the electrode lead 104 comprises a tubular lead body 110 and one or more stimulation elements or electrodes 112 supported at a distal end 114 by the lead body 110 .
  • the electrodes 112 are separated from each other by an insulative portion or element 116 .
  • the lead body 110 insulates electrical wires 118 or other conductor that connects the control unit 102 to the electrodes 112 .
  • the lead body 110 can be in the form of an insulating jacket typically comprising silicone, polyurethane or other flexible, biocompatible electrically insulating material. Additional electrode leads 104 or physiological sensors may be coupled to the control unit 102 .
  • control unit 102 comprises circuitry including at least one processor for processing electrical signals received from the one or more electrodes 112 or physiological sensors (not shown). In one embodiment, the control unit 102 is also configured to apply an electrical current or waveform to the tissue of the patient through the one or more electrodes 112 that are in contact with the tissue. In one embodiment, the control unit 102 receives power from an internal battery (not shown).
  • control unit 102 is enclosed within a hermetically sealed metal housing 113 commonly referred to as a “can.”
  • the can 113 generally comprises first and second halves that are joined together in a laser-welding operation about their perimeters after the battery power supply and electronic circuitry are inserted in the space defined by the two halves of the can.
  • a header 115 includes a connector block that may be molded in the header or inserted after the header has been molded. Feed-through conductors from the electronic circuitry within the can are coupled to electrical contacts of the connector block.
  • the connector block includes one or more ports, each of which receives the connector 108 of each lead 104 and electrically couples the connector 108 to the electronic circuitry or control unit 102 contained within the can 113 via the feed-through conductors.
  • the distal end 114 of the electrode lead 104 can be anchored to pelvic tissue of the patient (e.g., urinary sphincter muscle, anal sphincter muscle, etc.) by means of a tissue anchor 120 , in accordance with embodiments of the invention.
  • a tissue anchor 120 in accordance with embodiments of the invention.
  • Embodiments of the anchor include a helical coil, mesh and other suitable components.
  • the anchor 120 operates to secure the position of the electrodes 112 in the desired tissue of the patient.
  • the anchor 120 is attached to a deployable member 122 that may be deployed from within the tubular lead body, as illustrated in FIG. 1 .
  • the deployable member 122 includes the one or more electrodes 112 , as shown in FIG. 1 .
  • the deployable member 122 has a retracted position, in which the deployable member 122 is received within the tubular lead body 110 , as shown in the simplified side view of FIG. 2 . While in this retracted position, the distal end 114 of the electrode lead 104 may be implanted in tissue 124 of a patient, as shown in the simplified side view of FIG. 3 . The implantation of the distal end 114 of the electrode lead 104 may be accomplished using conventional techniques, such as with an introducer needle. Once the distal end 114 of the electrode lead 104 is positioned as desired within the tissue 124 , the physician may use a deployment mechanism to move the deployable member 122 out an opening 126 of the tubular lead member 110 , as illustrated in FIGS. 1 and 3 .
  • the tissue anchor 120 is attached to the deployable member 122 and comprises mesh, as illustrated in FIG. 3 .
  • FIG. 4 is a simplified side view of the distal end 114 of the electrode lead 104 with the deployable member 122 having the mesh anchor 120 in the deployed position within tissue 124 of a patient.
  • FIG. 5 is a cross-sectional view of the deployable member 122 taken generally along line 5 - 5 of FIG. 4 and illustrates the implantation of the distal end 114 of the electrode lead 104 .
  • the mesh anchor 120 is preferably a bio-compatible open matrix mesh, such as a mesh constructed of polypropylene monofilament. A portion of the mesh anchor 120 is attached to the deployable member 122 at a location 128 . Exemplary means for attaching the mesh anchor 120 to the deployable member 122 include sutures, glue, anchors, or other suitable bio-compatible methods.
  • the mesh anchor 120 comprises one or more mesh sections or wings, such as wings 130 and 132 .
  • the mesh anchor 120 has a compact state and an expanded state.
  • the mesh anchor 120 is placed in the compact state when retracted within the tubular lead 110 ( FIG. 2 ).
  • the deployable member 122 is moved through the opening 126 , the mesh anchor 120 expands, as shown in FIGS. 3-5 , to promote tissue ingrowth through the mesh and anchor the deployable member 122 and the distal end 114 of the electrode lead 104 in place within the tissue 124 .
  • at least a portion of the mesh anchor 120 is displaced a greater distance from the deployable member 122 when in the expanded state than when in the compact state.
  • the mesh anchor 120 has a shape memory that drives the mesh to a preset expanded, quiescent shape, in which at least a portion of the mesh anchor 120 extends away from the deployable member 122 and into the surrounding tissue 124 .
  • the “quiescent shape” of the mesh anchor 120 is one in which the mesh will naturally return to after being deformed, such as when compressed into a compact state.
  • the expanded state of the mesh wings 130 and 132 is one in which the wings 130 and 132 are displaced from each other, such as illustrated FIG. 5 .
  • a nitinol structure is secured to the mesh and promotes the expansion of the mesh.
  • one embodiment of the mesh anchor 120 has a shape memory that encourages separation of the one or more wings, such as wings 130 and 132 , within the tissue 124 .
  • the mesh anchor 120 comprises the one or more electrodes 112 that are used to deliver electrical signals to the tissue 124 .
  • one or more conductive fibers 134 are attached to the mesh anchor 120 and conduct electrical signals from the deployable member 122 , such as electrodes 112 on the deployable member 122 , to the tissue 124 , as shown in FIG. 4 .
  • the conductive fibers 134 are electrically insulated from the tissue 124 and conduct the electrical signals to one or more electrically conductive nodes or electrodes 136 that are attached to the mesh anchor 120 and deliver the electrical signals to the tissue 124 .
  • FIG. 6 is a simplified side cross-sectional view of a distal end 114 of an electrode lead 104 in accordance with embodiments of the invention.
  • FIG. 7 is a cross-sectional view of the electrode lead 104 of FIG. 6 taken generally along line 7 - 7 .
  • the lead 104 comprises the tubular lead body 110 , a rotatable member 138 within the distal end 114 of the tubular lead body 110 , the deployable member 122 , and a deployment mechanism 139 .
  • electrode lead 104 includes one or more electrodes 112 that are supported by the lead body 110 , such as through the attachment of the electrodes 112 to the lead body 110 , or to the deployable member 122 , for example.
  • the electrodes 112 are not illustrated in FIG. 6 or 7 in order to simplify the drawings.
  • the rotatable member 138 is configured to rotate about a central axis 140 , which is generally aligned with the longitudinal axis of the tubular lead body 110 .
  • a distal end 142 of the rotatable member 138 is attached to the deployable member 122 .
  • the electrode lead 104 includes an extension member 144 having a distal end 146 that is attached to a proximal end 148 of the rotatable member 138 , as shown in FIG. 6 .
  • the extension member 144 has a proximal end 150 that extends to the proximal end 106 of the tubular lead body 104 , as shown in FIG. 2 .
  • a physician may rotate the proximal end 150 of the extension member 144 by hand to drive the rotation of the rotatable member 138 about the central axis 140 .
  • a motorized device or other tool may be used to drive the rotation of the proximal end 150 .
  • the extension member 144 comprises a coil, as illustrated in FIG. 6 .
  • At least one electrical conductor extends through the tubular lead body 110 and is electrically coupled to the one or more electrodes 112 .
  • the rotatable member 138 is formed of or includes an electrically conductive material that conducts electrical signals to the one or more electrodes 112 through the deployable member 122 .
  • the extension member 144 is used to conduct the electrical signals to the rotatable member 138 .
  • separate electrical conductors such as wires 118 ( FIG. 1 ) may extend through the lead body 110 to the rotatable member 138 .
  • Other configurations are also possible.
  • the deployment mechanism 139 is configured to drive the deployable member 122 along the central axis 140 responsive to the rotation of the rotatable member 138 about the central axis 140 to move the deployable member 122 between the retracted position ( FIG. 2 ) and the deployed position ( FIGS. 1 and 3 ).
  • the deployment mechanism 139 comprises a threaded section 160 of the rotatable member 138 and a threaded section 162 of the deployable member 122 , as shown in FIG. 6 .
  • the threaded section 160 of the rotatable member 138 is located on an exterior surface of the rotatable member 138
  • the threaded section 162 is located on an interior surface of a bore 164 of the deployable member 122 .
  • this arrangement may be reversed by placing the threaded section 160 of the rotatable member 138 on an interior surface of a bore, and arranging the threaded section 162 of the deployable member 122 on an exterior surface that is received within the bore of the rotatable member 138 .
  • the threaded sections 160 and 162 intermesh and the rotation of the rotatable member 138 about the central axis 140 relative to the deployable member 122 drives the deployable member 122 along the central axis 140 relative to the rotatable member 138 and the tubular lead body 110 .
  • the position of the rotatable member 138 along the central axis 140 is fixed relative to the tubular lead body 110 . In one embodiment, this is accomplished using one or more stop members 166 of the lead body 110 that engage a member 168 of the rotatable member 138 , as shown in FIG. 6 .
  • the electrode lead 104 includes a guide 170 that is configured to prevent the deployable member 122 from rotating about the central axis 140 relative to the lead body 110 .
  • the guide 170 comprises a slot 172 in an exterior wall 174 of the deployable member 122 , and a protrusion 176 extending from an interior wall 178 of the lead body 110 , as shown in FIGS. 6 and 7 .
  • the protrusion 176 slides within the slot 172 and prevents the deployable member 122 from rotating about the central axis 140 relative to the lead body 110 .
  • the deployable member 122 does not rotate about the central axis 140 with the rotation of the rotatable member 138 .
  • the electrode lead 104 includes a pair of the guides 170 , as shown in FIGS. 6 and 7 . Additional guides may also be used as necessary.
  • FIG. 8 is a simplified side cross-sectional view of a distal end 114 of electrode lead 104 in accordance with embodiments of the invention.
  • the deployable member 122 is coupled to the distal end 142 through a suitable mechanical connection.
  • the mechanical connection allows the deployable member 122 to remain in a fixed angular position about the central axis 140 as the rotatable member 138 rotates about the axis 140 .
  • the mechanical coupling between the deployable member 122 and the rotatable member 138 can take on many different forms while providing the desired function described above.
  • the mechanical coupling comprises a ball member 186 coupled to the rotatable member 138 , and a socket member 188 coupled to the deployable member 122 .
  • the ball member 186 is received within the socket member 188 and is able to rotate within the socket member 188 .
  • a low friction interface 190 is formed between the exterior surface of the ball member 186 and the interior surface of the socket member 188 .
  • the low friction interface 190 may be formed using a suitable lubricant, an insert covering the exterior of the ball member 186 , an insert covering the interior surface of the socket member 188 , and/or other suitable techniques for forming a low friction interface.
  • the deployable member 122 is restricted from rotating about the axis 140 relative to the lead body 110 .
  • the lead 104 includes one or more of the guides 170 described above, as shown in FIG. 8 .
  • FIG. 8 Another embodiment of the deployment mechanism 139 , illustrated in FIG. 8 , comprises a threaded section 194 on the interior wall 178 of the tubular lead member 110 , and a threaded section 196 on the exterior surface 198 of the rotatable member 138 .
  • the threaded sections 194 and 196 are positioned to intermesh with each other. Rotation of the rotatable member 138 about the axis 140 drives movement of the rotatable member 138 along the axis 140 relative to the lead body 110 .
  • the rotation of the rotatable member 138 about the axis 140 also drives movement of the deployable member 122 along the axis 140 .
  • the deployment mechanism 139 drives movement of the deployable member 122 along the axis 140 relative to the lead body 110 through the rotation of the rotatable member 138 , and it may be used to deploy the deployable member 122 from within the lead body 110 through the opening 126 into desired tissue of a patient, and retract the deployable member 122 back into the lead body 110 through the opening 126 , as described above.
  • the movement of the rotatable member 138 along the central axis 140 is restricted by one or more stops 200 projecting from the interior wall 178 of the lead body 110 and stops 202 extending radially from the rotatable member 138 .
  • the stops 200 of the lead body 110 engage the stops 202 to limit the distance the rotatable member 138 may travel along the central axis 140 and, thus, the distance the deployable member 122 may travel along the axis 140 relative to the tubular lead member 110 .
  • the deployable member 122 and/or the connected anchor 120 may include the one or more electrodes or stimulation elements 112 .
  • electrical signals are delivered to the one or more electrodes 112 on the deployable member 122 through an electrical conductive path that extends to the proximal end 106 of the tubular lead body 110 .
  • the electrical signals are conducted to the rotatable member 138 using, for example, the extension member 144 , or other suitable conductor.
  • an electrical connection is formed between the rotatable member 138 and the deployable member 122 such that electrical signals conducted to the rotatable member 138 may be delivered to the one or more electrodes 112 that are connected to the deployable member 122 .
  • the electrical connection comprises a coil 204 or other suitable component that rotates about the central axis 140 with the rotation of the rotatable member 138 .
  • the coil 204 or other suitable component is placed in sliding contact with the deployable member 122 to conduct electrical signals from the rotatable member 138 to the deployable member 122 .
  • the electrical connection allows electrical signals to be delivered to the one or more electrodes 112 through the deployable member 122 while maintaining the ability to rotate the rotatable member 138 relative to the deployable member 122 .
  • the electrical connection is formed between the ball member 186 and the socket member 188 .
  • FIG. 9 is a flowchart illustrating a method of using the electrode lead 104 formed in accordance with one or more embodiments described above.
  • an electrode lead 104 formed in accordance with one or more of the embodiments described above is provided.
  • the distal end 114 of the tubular lead member 110 is positioned approximate target tissue 124 of a patient, as shown in FIG. 2 .
  • the rotatable member 138 is rotated relative to the tubular lead member 110 . As discussed above, this may be accomplished through the rotation of the proximal end 143 of the extension member 138 by the physician.
  • the deployable member 122 is driven along the central axis 140 and out the opening 146 at the distal end 114 of the tubular lead member 110 using the deployment mechanism 139 , as shown in FIG. 3 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

In a method, an electrode lead is provided that includes a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism. The rotatable member is contained within a distal end of the tubular lead body. The deployable member is attached to the rotatable member and comprises a tissue anchor that includes mesh. Also in the method, the distal end of the tubular lead body is positioned proximate target tissue of a patient. The rotatable member is rotated relative to the tubular lead body. The deployable member is driven along the central axis, out the distal end of the tubular lead body, and into the target tissue using the deployment mechanism responsive to the rotation of the rotatable member. The deployment member does not rotate about the central axis with the rotation of the rotatable member.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • The present application claims the benefit of U.S. provisional patent application Ser. No. 61/494,950 filed Jun. 9, 2011, the content of which is hereby incorporated by reference in its entirety.
  • FIELD OF THE INVENTION
  • Embodiments of the present invention generally relate to an anchor that facilitates securing devices or components to internal tissue of a patient and preventing migration of the devices or components from their intended location relative to the tissue of the patient.
  • BACKGROUND OF THE INVENTION
  • Implantable electronic stimulator devices, such as neuromuscular stimulation devices, have been disclosed for use in the treatment of various pelvic conditions, such as urinary incontinence, fecal incontinence and sexual dysfunction. Such devices generally include one or more electrodes that are coupled to a control unit by electrode leads. Electrical signals are applied to the desired pelvic tissue of the patient through the electrode leads in order to treat the condition of the patient. Exemplary implantable electronic stimulator devices and uses of the devices are disclosed in U.S. Pat. Nos. 6,354,991, 6,652,449, 6,712,772 and 6,862,480, each of which is hereby incorporated by reference in its entirety.
  • Electrical leads utilize anchors to secure the one or more electrodes in tissue of the patient. Exemplary anchors include helical coils and mesh, such as that disclosed in (A92.12-0136), which is incorporated herein by reference in its entirety. It is desirable, for example, that such anchors prevent relative movement between the anchor and the tissue in which the anchor in embedded, are easy to install in the tissue, avoid damaging the tissue during the implantation procedure, can be removed without significantly damaging the tissue, and/or have other features or benefits recognized by those skilled in the art.
  • SUMMARY
  • Embodiments of the invention are directed to an implantable electrode lead. In some embodiments, the electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism. The rotatable member is contained within a distal end of the tubular lead body. The deployable member is attached to the rotatable member and comprises a tissue anchor. The deployment mechanism is configured to drive the deployable member along a central axis and out the distal end of the tubular lead body responsive to rotation of the rotatable member about the central axis. In one embodiment, the deployable member does not rotate about the central axis with the rotation of the rotatable member.
  • Another embodiment is directed to a method, in which an electrode lead is provided. The electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism. The rotatable member is contained within a distal end of the tubular lead body. The deployable member is attached to the rotatable member and comprises a tissue anchor. Also in the method, the distal end of the tubular lead body is positioned proximate target tissue of a patient. The rotatable member is rotated relative to the tubular lead body. The deployable member is driven along the central axis, out the distal end of the tubular lead body, and into the target tissue using the deployment mechanism responsive to the rotation of the rotatable member. In one embodiment, the deployable member does not rotate about the central axis with the rotation of the rotatable member.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a side plan view of an exemplary electronic stimulator device, in accordance with embodiments of the invention.
  • FIGS. 2 and 3 are simplified views of an electrode lead formed in accordance with embodiments of the invention positioned within tissue of a patient.
  • FIG. 4 is a simplified side view of a distal end of an electrode lead having a mesh anchor in a deployed position, in accordance with embodiments of the invention.
  • FIG. 5 is a cross-sectional view of the portion of the lead of FIG. 4 taken generally along line 5-5.
  • FIG. 6 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention.
  • FIG. 7 is a cross-sectional view of the electrode lead of FIG. 6 taken generally along line 7-7.
  • FIG. 8 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention.
  • FIG. 9 is a flowchart illustrating a method of using the electrode lead formed in accordance with one or more embodiments of the invention.
  • DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
  • Embodiments of the invention are described more fully hereinafter with reference to the accompanying drawings. The various embodiments of the invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Elements that are identified using the same or similar reference characters refer to the same or similar elements.
  • FIG. 1 is a side plan view of an exemplary electronic stimulator device 100, in accordance with embodiments of the invention. The stimulator device 100 is configured for implantation into a pelvic region of a patient to provide muscle and/or nerve stimulation that is used to control and/or treat a pelvic condition of the patient, such as pelvic pain, urinary incontinence, fecal incontinence, erectile dysfunction or other pelvic condition that may be treated through electrical stimulation.
  • In one embodiment, the device 100 comprises a control unit 102 and one or more electrode leads 104, a proximal end 106 of which is electrically coupled to the control unit 102 via a connector 108. In one embodiment, the electrode lead 104 comprises a tubular lead body 110 and one or more stimulation elements or electrodes 112 supported at a distal end 114 by the lead body 110. In one embodiment, the electrodes 112 are separated from each other by an insulative portion or element 116. The lead body 110 insulates electrical wires 118 or other conductor that connects the control unit 102 to the electrodes 112. The lead body 110 can be in the form of an insulating jacket typically comprising silicone, polyurethane or other flexible, biocompatible electrically insulating material. Additional electrode leads 104 or physiological sensors may be coupled to the control unit 102.
  • In one embodiment, the control unit 102 comprises circuitry including at least one processor for processing electrical signals received from the one or more electrodes 112 or physiological sensors (not shown). In one embodiment, the control unit 102 is also configured to apply an electrical current or waveform to the tissue of the patient through the one or more electrodes 112 that are in contact with the tissue. In one embodiment, the control unit 102 receives power from an internal battery (not shown).
  • In one embodiment, the control unit 102 is enclosed within a hermetically sealed metal housing 113 commonly referred to as a “can.” The can 113 generally comprises first and second halves that are joined together in a laser-welding operation about their perimeters after the battery power supply and electronic circuitry are inserted in the space defined by the two halves of the can.
  • A header 115 includes a connector block that may be molded in the header or inserted after the header has been molded. Feed-through conductors from the electronic circuitry within the can are coupled to electrical contacts of the connector block. The connector block includes one or more ports, each of which receives the connector 108 of each lead 104 and electrically couples the connector 108 to the electronic circuitry or control unit 102 contained within the can 113 via the feed-through conductors.
  • The distal end 114 of the electrode lead 104 can be anchored to pelvic tissue of the patient (e.g., urinary sphincter muscle, anal sphincter muscle, etc.) by means of a tissue anchor 120, in accordance with embodiments of the invention. Embodiments of the anchor include a helical coil, mesh and other suitable components. The anchor 120 operates to secure the position of the electrodes 112 in the desired tissue of the patient.
  • In one embodiment, the anchor 120 is attached to a deployable member 122 that may be deployed from within the tubular lead body, as illustrated in FIG. 1. In one embodiment, the deployable member 122 includes the one or more electrodes 112, as shown in FIG. 1.
  • In one embodiment, the deployable member 122 has a retracted position, in which the deployable member 122 is received within the tubular lead body 110, as shown in the simplified side view of FIG. 2. While in this retracted position, the distal end 114 of the electrode lead 104 may be implanted in tissue 124 of a patient, as shown in the simplified side view of FIG. 3. The implantation of the distal end 114 of the electrode lead 104 may be accomplished using conventional techniques, such as with an introducer needle. Once the distal end 114 of the electrode lead 104 is positioned as desired within the tissue 124, the physician may use a deployment mechanism to move the deployable member 122 out an opening 126 of the tubular lead member 110, as illustrated in FIGS. 1 and 3.
  • In one embodiment, the tissue anchor 120 is attached to the deployable member 122 and comprises mesh, as illustrated in FIG. 3. FIG. 4 is a simplified side view of the distal end 114 of the electrode lead 104 with the deployable member 122 having the mesh anchor 120 in the deployed position within tissue 124 of a patient. FIG. 5 is a cross-sectional view of the deployable member 122 taken generally along line 5-5 of FIG. 4 and illustrates the implantation of the distal end 114 of the electrode lead 104. In one embodiment, the mesh anchor 120 is preferably a bio-compatible open matrix mesh, such as a mesh constructed of polypropylene monofilament. A portion of the mesh anchor 120 is attached to the deployable member 122 at a location 128. Exemplary means for attaching the mesh anchor 120 to the deployable member 122 include sutures, glue, anchors, or other suitable bio-compatible methods. In one embodiment, the mesh anchor 120 comprises one or more mesh sections or wings, such as wings 130 and 132.
  • In one embodiment, the mesh anchor 120 has a compact state and an expanded state. The mesh anchor 120 is placed in the compact state when retracted within the tubular lead 110 (FIG. 2). When the deployable member 122 is moved through the opening 126, the mesh anchor 120 expands, as shown in FIGS. 3-5, to promote tissue ingrowth through the mesh and anchor the deployable member 122 and the distal end 114 of the electrode lead 104 in place within the tissue 124. In general, at least a portion of the mesh anchor 120 is displaced a greater distance from the deployable member 122 when in the expanded state than when in the compact state.
  • In one embodiment, the mesh anchor 120 has a shape memory that drives the mesh to a preset expanded, quiescent shape, in which at least a portion of the mesh anchor 120 extends away from the deployable member 122 and into the surrounding tissue 124. As used herein, the “quiescent shape” of the mesh anchor 120 is one in which the mesh will naturally return to after being deformed, such as when compressed into a compact state. In one embodiment, the expanded state of the mesh wings 130 and 132 is one in which the wings 130 and 132 are displaced from each other, such as illustrated FIG. 5. In one embodiment, a nitinol structure is secured to the mesh and promotes the expansion of the mesh. Thus, one embodiment of the mesh anchor 120 has a shape memory that encourages separation of the one or more wings, such as wings 130 and 132, within the tissue 124.
  • In one embodiment, the mesh anchor 120 comprises the one or more electrodes 112 that are used to deliver electrical signals to the tissue 124. In one embodiment, one or more conductive fibers 134 are attached to the mesh anchor 120 and conduct electrical signals from the deployable member 122, such as electrodes 112 on the deployable member 122, to the tissue 124, as shown in FIG. 4. In one embodiment, the conductive fibers 134 are electrically insulated from the tissue 124 and conduct the electrical signals to one or more electrically conductive nodes or electrodes 136 that are attached to the mesh anchor 120 and deliver the electrical signals to the tissue 124.
  • FIG. 6 is a simplified side cross-sectional view of a distal end 114 of an electrode lead 104 in accordance with embodiments of the invention. FIG. 7 is a cross-sectional view of the electrode lead 104 of FIG. 6 taken generally along line 7-7. In one embodiment, the lead 104 comprises the tubular lead body 110, a rotatable member 138 within the distal end 114 of the tubular lead body 110, the deployable member 122, and a deployment mechanism 139. In one embodiment, electrode lead 104 includes one or more electrodes 112 that are supported by the lead body 110, such as through the attachment of the electrodes 112 to the lead body 110, or to the deployable member 122, for example. The electrodes 112 are not illustrated in FIG. 6 or 7 in order to simplify the drawings.
  • In one embodiment, the rotatable member 138 is configured to rotate about a central axis 140, which is generally aligned with the longitudinal axis of the tubular lead body 110. In one embodiment, a distal end 142 of the rotatable member 138 is attached to the deployable member 122. In one embodiment, the electrode lead 104 includes an extension member 144 having a distal end 146 that is attached to a proximal end 148 of the rotatable member 138, as shown in FIG. 6. In one embodiment, the extension member 144 has a proximal end 150 that extends to the proximal end 106 of the tubular lead body 104, as shown in FIG. 2. A physician may rotate the proximal end 150 of the extension member 144 by hand to drive the rotation of the rotatable member 138 about the central axis 140. Alternatively, a motorized device or other tool may be used to drive the rotation of the proximal end 150. In one embodiment, the extension member 144 comprises a coil, as illustrated in FIG. 6.
  • In one embodiment, at least one electrical conductor extends through the tubular lead body 110 and is electrically coupled to the one or more electrodes 112. In one embodiment, when the one or more electrodes 112 are disposed in or on the deployable member 122, or are otherwise electrically coupled to the deployable member 122, the rotatable member 138 is formed of or includes an electrically conductive material that conducts electrical signals to the one or more electrodes 112 through the deployable member 122. In one embodiment, the extension member 144 is used to conduct the electrical signals to the rotatable member 138. Alternatively, separate electrical conductors, such as wires 118 (FIG. 1) may extend through the lead body 110 to the rotatable member 138. Other configurations are also possible.
  • One embodiment of the deployment mechanism 139 is configured to drive the deployable member 122 along the central axis 140 responsive to the rotation of the rotatable member 138 about the central axis 140 to move the deployable member 122 between the retracted position (FIG. 2) and the deployed position (FIGS. 1 and 3). In one embodiment, the deployment mechanism 139 comprises a threaded section 160 of the rotatable member 138 and a threaded section 162 of the deployable member 122, as shown in FIG. 6. In one embodiment, the threaded section 160 of the rotatable member 138 is located on an exterior surface of the rotatable member 138, and the threaded section 162 is located on an interior surface of a bore 164 of the deployable member 122. However, it is understood that this arrangement may be reversed by placing the threaded section 160 of the rotatable member 138 on an interior surface of a bore, and arranging the threaded section 162 of the deployable member 122 on an exterior surface that is received within the bore of the rotatable member 138.
  • In one embodiment, the threaded sections 160 and 162 intermesh and the rotation of the rotatable member 138 about the central axis 140 relative to the deployable member 122 drives the deployable member 122 along the central axis 140 relative to the rotatable member 138 and the tubular lead body 110. This allows the deployable member 122 to be deployed from within the tubular lead body 110 through the opening 126, or retracted into the tubular lead body 110, through the rotation of the rotatable member 138, which is driven, for example, by the rotation of the extension portion 144.
  • In one embodiment, the position of the rotatable member 138 along the central axis 140 is fixed relative to the tubular lead body 110. In one embodiment, this is accomplished using one or more stop members 166 of the lead body 110 that engage a member 168 of the rotatable member 138, as shown in FIG. 6.
  • In one embodiment, the electrode lead 104 includes a guide 170 that is configured to prevent the deployable member 122 from rotating about the central axis 140 relative to the lead body 110. In one embodiment, the guide 170 comprises a slot 172 in an exterior wall 174 of the deployable member 122, and a protrusion 176 extending from an interior wall 178 of the lead body 110, as shown in FIGS. 6 and 7. As the deployable member 122 is moved along the central axis 140 relative to the lead body 110 responsive to the rotation of the rotatable member 138, the protrusion 176 slides within the slot 172 and prevents the deployable member 122 from rotating about the central axis 140 relative to the lead body 110. As a result, the deployable member 122 does not rotate about the central axis 140 with the rotation of the rotatable member 138. In one embodiment, the electrode lead 104 includes a pair of the guides 170, as shown in FIGS. 6 and 7. Additional guides may also be used as necessary.
  • FIG. 8 is a simplified side cross-sectional view of a distal end 114 of electrode lead 104 in accordance with embodiments of the invention. In one embodiment, the deployable member 122 is coupled to the distal end 142 through a suitable mechanical connection. In one embodiment, the mechanical connection allows the deployable member 122 to remain in a fixed angular position about the central axis 140 as the rotatable member 138 rotates about the axis 140. The mechanical coupling between the deployable member 122 and the rotatable member 138 can take on many different forms while providing the desired function described above.
  • In one exemplary embodiment, the mechanical coupling comprises a ball member 186 coupled to the rotatable member 138, and a socket member 188 coupled to the deployable member 122. The ball member 186 is received within the socket member 188 and is able to rotate within the socket member 188. In one embodiment, a low friction interface 190 is formed between the exterior surface of the ball member 186 and the interior surface of the socket member 188. The low friction interface 190 may be formed using a suitable lubricant, an insert covering the exterior of the ball member 186, an insert covering the interior surface of the socket member 188, and/or other suitable techniques for forming a low friction interface.
  • In one embodiment, the deployable member 122 is restricted from rotating about the axis 140 relative to the lead body 110. In one embodiment, the lead 104 includes one or more of the guides 170 described above, as shown in FIG. 8.
  • Another embodiment of the deployment mechanism 139, illustrated in FIG. 8, comprises a threaded section 194 on the interior wall 178 of the tubular lead member 110, and a threaded section 196 on the exterior surface 198 of the rotatable member 138. The threaded sections 194 and 196 are positioned to intermesh with each other. Rotation of the rotatable member 138 about the axis 140 drives movement of the rotatable member 138 along the axis 140 relative to the lead body 110. Due to the mechanical coupling between the distal end 142 of the rotatable member 138 and the deployable member 122, the rotation of the rotatable member 138 about the axis 140 also drives movement of the deployable member 122 along the axis 140. Thus, the deployment mechanism 139 drives movement of the deployable member 122 along the axis 140 relative to the lead body 110 through the rotation of the rotatable member 138, and it may be used to deploy the deployable member 122 from within the lead body 110 through the opening 126 into desired tissue of a patient, and retract the deployable member 122 back into the lead body 110 through the opening 126, as described above.
  • In one embodiment, the movement of the rotatable member 138 along the central axis 140 is restricted by one or more stops 200 projecting from the interior wall 178 of the lead body 110 and stops 202 extending radially from the rotatable member 138. The stops 200 of the lead body 110 engage the stops 202 to limit the distance the rotatable member 138 may travel along the central axis 140 and, thus, the distance the deployable member 122 may travel along the axis 140 relative to the tubular lead member 110.
  • As discussed above, the deployable member 122 and/or the connected anchor 120 may include the one or more electrodes or stimulation elements 112. As discussed above, electrical signals are delivered to the one or more electrodes 112 on the deployable member 122 through an electrical conductive path that extends to the proximal end 106 of the tubular lead body 110. In one embodiment, the electrical signals are conducted to the rotatable member 138 using, for example, the extension member 144, or other suitable conductor. In one embodiment, an electrical connection is formed between the rotatable member 138 and the deployable member 122 such that electrical signals conducted to the rotatable member 138 may be delivered to the one or more electrodes 112 that are connected to the deployable member 122. In one embodiment, the electrical connection comprises a coil 204 or other suitable component that rotates about the central axis 140 with the rotation of the rotatable member 138. The coil 204 or other suitable component is placed in sliding contact with the deployable member 122 to conduct electrical signals from the rotatable member 138 to the deployable member 122. The electrical connection allows electrical signals to be delivered to the one or more electrodes 112 through the deployable member 122 while maintaining the ability to rotate the rotatable member 138 relative to the deployable member 122. In accordance with another embodiment, the electrical connection is formed between the ball member 186 and the socket member 188.
  • FIG. 9 is a flowchart illustrating a method of using the electrode lead 104 formed in accordance with one or more embodiments described above. At 210, an electrode lead 104 formed in accordance with one or more of the embodiments described above is provided. At 212, the distal end 114 of the tubular lead member 110 is positioned approximate target tissue 124 of a patient, as shown in FIG. 2. At 214, the rotatable member 138 is rotated relative to the tubular lead member 110. As discussed above, this may be accomplished through the rotation of the proximal end 143 of the extension member 138 by the physician. At 216, the deployable member 122 is driven along the central axis 140 and out the opening 146 at the distal end 114 of the tubular lead member 110 using the deployment mechanism 139, as shown in FIG. 3.
  • Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention.

Claims (8)

1-14. (canceled)
15. A method comprising:
providing and electrode lead comprising:
a tubular lead body;
an electrode supported by the lead body;
a rotatable member within a distal end of the tubular lead body;
a deployable member attached to the rotatable member and comprising a tissue anchor, the tissue anchor comprising mesh; and
a deployment mechanism;
positioning the distal end of the tubular lead body proximate target tissue of a patient;
rotating the rotatable member relative to the tubular lead body; and
driving the deployable member along the central axis out the distal end of the tubular lead body and into the target tissue using the deployment mechanism responsive to rotating the rotatable member;
wherein the deployable member does not rotate about the central axis with the rotation of the rotatable member.
16. The method of claim 15, further comprising driving the anchor into the target tissue responsive to driving the deployable member along the central axis.
17. (canceled)
18. The method of claim 15, wherein the deployable member includes the electrode.
19. The method of claim 15, wherein:
the deployment mechanism comprises:
a first threaded section attached to the rotatable member; and
a second threaded section attached to the deployable member that intermeshes with the first threaded section; and
driving the deployable member along the central axis comprises intermeshing the first and second threaded sections during rotation of the rotatable member.
20. The method of claim 15, wherein:
the deployment mechanism comprises:
a first threaded section on an interior wall of the tubular lead body; and
a second threaded section on an exterior wall of the rotatable member that intermeshes with the first threaded section;
driving the deployable member along the central axis comprises intermeshing the first and second threaded sections during rotation of the rotatable member.
21. The method of claim 15, wherein:
the electrode is attached to the mesh; and
the method comprises delivering electrical signals to the electrode.
US14/947,502 2011-06-09 2015-11-20 Electrode lead including a deployable tissue anchor Abandoned US20160089531A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/947,502 US20160089531A1 (en) 2011-06-09 2015-11-20 Electrode lead including a deployable tissue anchor

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161494950P 2011-06-09 2011-06-09
US13/490,600 US9220887B2 (en) 2011-06-09 2012-06-07 Electrode lead including a deployable tissue anchor
US14/947,502 US20160089531A1 (en) 2011-06-09 2015-11-20 Electrode lead including a deployable tissue anchor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/490,600 Division US9220887B2 (en) 2011-06-09 2012-06-07 Electrode lead including a deployable tissue anchor

Publications (1)

Publication Number Publication Date
US20160089531A1 true US20160089531A1 (en) 2016-03-31

Family

ID=47293799

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/490,600 Active 2033-05-18 US9220887B2 (en) 2011-06-09 2012-06-07 Electrode lead including a deployable tissue anchor
US14/947,502 Abandoned US20160089531A1 (en) 2011-06-09 2015-11-20 Electrode lead including a deployable tissue anchor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/490,600 Active 2033-05-18 US9220887B2 (en) 2011-06-09 2012-06-07 Electrode lead including a deployable tissue anchor

Country Status (1)

Country Link
US (2) US9220887B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013537835A (en) 2010-09-28 2013-10-07 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ Devices and methods for positioning electrodes in tissue
US9981121B2 (en) 2014-04-28 2018-05-29 Medtronic, Inc. Implantable medical devices, systems and components thereof
EP3139994B1 (en) * 2014-05-09 2024-05-22 Merit Medical Systems, Inc. Device for positioning an electrode in a body cavity
US10709886B2 (en) * 2017-02-28 2020-07-14 Boston Scientific Neuromodulation Corporation Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using
US10835739B2 (en) 2017-03-24 2020-11-17 Boston Scientific Neuromodulation Corporation Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using
US11565105B2 (en) * 2018-10-05 2023-01-31 Biotronik Se & Co. Kg Lead anchor for a neuromodulation lead

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4257428A (en) * 1977-12-09 1981-03-24 Barton Steven A Retractable stimulation electrode apparatus and method
US20020151948A1 (en) * 1998-04-30 2002-10-17 Medtronic, Inc. Apparatus and method for expanding a simulation lead body in situ
US20070050003A1 (en) * 2005-08-30 2007-03-01 Cardiac Pacemakers, Inc. Device on lead to prevent perforation and/or fixate lead
US20100049289A1 (en) * 2007-07-10 2010-02-25 Ams Research Corporation Tissue anchor

Family Cites Families (283)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3667477A (en) 1966-11-25 1972-06-06 Canadian Patents Dev Implantable vesical stimulator
GB1227186A (en) 1968-09-18 1971-04-07
CH507005A (en) 1969-03-26 1971-05-15 Inst Medicina Farmacie Device for electrical neurostimulation for the evacuation of the neurogenic urinary bladder
US3662758A (en) 1969-06-30 1972-05-16 Mentor Corp Stimulator apparatus for muscular organs with external transmitter and implantable receiver
US3646940A (en) 1969-07-15 1972-03-07 Univ Minnesota Implantable electronic stimulator electrode and method
US3640284A (en) 1970-01-05 1972-02-08 Philip A De Langis Apparatus for electrotherapy of the pubococcygeus
GB1434524A (en) 1972-04-27 1976-05-05 Nat Res Dev Urinary control apparatus
GB1452262A (en) 1972-07-13 1976-10-13 Devices Implants Ltd Pessary ring electrode system
US3941136A (en) 1973-11-21 1976-03-02 Neuronyx Corporation Method for artificially inducing urination, defecation, or sexual excitation
AT332528B (en) 1974-10-18 1976-10-11 Nemec Hans ELECTROMEDICAL APPARATUS
US3926178A (en) 1975-01-17 1975-12-16 Alvin N Feldzamen Apparatus for aiding the voluntary exercising of sphincter muscles
US3983865A (en) 1975-02-05 1976-10-05 Shepard Richard S Method and apparatus for myofunctional biofeedback
US3983881A (en) 1975-05-21 1976-10-05 Telectronics Pty. Limited Muscle stimulator
US4010758A (en) 1975-09-03 1977-03-08 Medtronic, Inc. Bipolar body tissue electrode
US4030509A (en) 1975-09-30 1977-06-21 Mieczyslaw Mirowski Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization
US3999555A (en) 1975-10-28 1976-12-28 Medtronic, Inc. Atrial pinch on lead and insertion tool
US4044774A (en) 1976-02-23 1977-08-30 Medtronic, Inc. Percutaneously inserted spinal cord stimulation lead
SE7604553L (en) 1976-04-21 1977-10-22 Svenska Utvecklings Ab ELECTRICAL STIMULATOR FOR REDUCING INCONTINENCE
US4136684A (en) 1977-02-07 1979-01-30 Scattergood Mark G Linear electromyographic biofeedback system
US4139006A (en) 1977-03-18 1979-02-13 Corey Arthur E Female incontinence device
US4222377A (en) 1977-06-27 1980-09-16 American Medical Systems, Inc. Pressure regulated artificial sphincter systems
US4217913A (en) 1977-10-10 1980-08-19 Medtronic, Inc. Body-implantable lead with protected, extendable tissue securing means
US4153059A (en) 1977-10-25 1979-05-08 Minnesota Mining And Manufacturing Company Urinary incontinence stimulator system
US4157087A (en) 1978-03-06 1979-06-05 Med General, Inc. Peripheral nerve stimulator
US4165750A (en) 1978-03-18 1979-08-28 Aleev Leonid S Bioelectrically controlled electric stimulator of human muscles
US4177819A (en) 1978-03-30 1979-12-11 Kofsky Harvey I Muscle stimulating apparatus
US4290420A (en) 1980-06-09 1981-09-22 Alberto Manetta Stress incontinence diagnostic and treatment device
SE435679B (en) 1980-09-17 1984-10-15 Landskrona Finans Ab STIMULATOR SYSTEM, INCLUDING ONE OF A RECHARGEABLE BATTERY DRIVE PULSE GENERATOR
YU272580A (en) 1980-10-23 1982-10-31 Inst Jozef Stefan Control circuit of a therapeutic stimulator for urine incontinency
GB2099304B (en) 1981-02-06 1985-01-30 Cornwell George Herbert Ivan Incontinence control devices
US4406288A (en) 1981-04-06 1983-09-27 Hugh P. Cash Bladder control device and method
US4402328A (en) 1981-04-28 1983-09-06 Telectronics Pty. Limited Crista terminalis atrial electrode lead
US4750494A (en) 1981-05-12 1988-06-14 Medtronic, Inc. Automatic implantable fibrillation preventer
US4414986A (en) 1982-01-29 1983-11-15 Medtronic, Inc. Biomedical stimulation lead
US4688575A (en) 1982-03-12 1987-08-25 Duvall Wilbur E Muscle contraction stimulation
US4492233A (en) 1982-09-14 1985-01-08 Wright State University Method and apparatus for providing feedback-controlled muscle stimulation
US4731083A (en) 1982-09-21 1988-03-15 The Johns Hopkins University Manually actuated hydraulic sphincter
US4571749A (en) 1982-09-21 1986-02-25 The Johns Hopkins University Manually actuated hydraulic sphincter
EP0109217A1 (en) 1982-11-05 1984-05-23 Craig Medical Products Limited Female incontinence device
US4542753A (en) 1982-12-22 1985-09-24 Biosonics, Inc. Apparatus and method for stimulating penile erectile tissue
US4515167A (en) 1983-02-28 1985-05-07 Hochman Joel S Device for the development, training and rehabilitation of the pubococcygeal and related perineal musculature of the female
DE3317118C2 (en) 1983-05-06 1986-08-28 Richard Wolf Gmbh, 7134 Knittlingen Device for the treatment of the female incontinentia urinae
US4550737A (en) 1983-10-12 1985-11-05 Peter Osypka Intravenously implantable electrode lead for use with cardiac pacemakers
US4585005A (en) 1984-04-06 1986-04-29 Regents Of University Of California Method and pacemaker for stimulating penile erection
US4607639A (en) 1984-05-18 1986-08-26 Regents Of The University Of California Method and system for controlling bladder evacuation
US4739764A (en) 1984-05-18 1988-04-26 The Regents Of The University Of California Method for stimulating pelvic floor muscles for regulating pelvic viscera
US4771779A (en) 1984-05-18 1988-09-20 The Regents Of The University Of California System for controlling bladder evacuation
US4703755A (en) 1984-05-18 1987-11-03 The Regents Of The University Of California Control system for the stimulation of two bodily functions
US4602624A (en) 1984-10-11 1986-07-29 Case Western Reserve University Implantable cuff, method of manufacture, and method of installation
US4628942A (en) 1984-10-11 1986-12-16 Case Western Reserve University Asymmetric shielded two electrode cuff
US4590949A (en) 1984-11-01 1986-05-27 Cordis Corporation Neural stimulating lead with stabilizing mechanism and method for using same
US4569351A (en) 1984-12-20 1986-02-11 University Of Health Sciences/The Chicago Medical School Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals
DE3673644D1 (en) 1986-05-12 1990-09-27 Univ California ELECTRONIC SYSTEM FOR NERVOUS STIMULATION OF PELVIC ORGANS.
US4785828A (en) 1986-10-06 1988-11-22 Empi, Inc. Vaginal stimulator for controlling urinary incontinence in women
DE3802158A1 (en) 1987-08-11 1989-02-23 Hoechst Ag DEVICE FOR APPLICATION OF IMPLANTS
DK162185C (en) 1987-09-15 1998-02-23 Linda Jonasson Device for preventing involuntary discharge of urine
US4881526A (en) 1988-05-27 1989-11-21 Empi, Inc. Intravaginal electrode and stimulation system for controlling female urinary incontinence
US5125925A (en) 1988-08-03 1992-06-30 Photoradiation Systems Intracavity laser catheter with sensing fiber
US4913164A (en) 1988-09-27 1990-04-03 Intermedics, Inc. Extensible passive fixation mechanism for lead assembly of an implantable cardiac stimulator
WO1990003766A1 (en) 1988-10-04 1990-04-19 Peter Emanuel Petros Surgical instrument prosthesis and method of utilisation of such
US5094242A (en) 1988-11-07 1992-03-10 Regents Of The University Of California Implantable nerve stimulation device
US5013292A (en) 1989-02-24 1991-05-07 R. Laborie Medical Corporation Surgical correction of female urinary stress incontinence and kit therefor
NL8901046A (en) 1989-04-26 1990-11-16 Enraf Nonius Delft ELECTRODE FOR STIMULATING AND / OR DETECTING THE MUSCULAR ACTIVITY OF A PATIENT'S ACCESSIBLE MUSCLES OR MUSCULAR GROUPS THROUGH A BODY OPEN.
US5061265A (en) 1989-06-20 1991-10-29 University Of Florida Laser treatment apparatus and method
US5074632A (en) 1990-03-07 1991-12-24 Health Research, Inc. Fiber optic diffusers and methods for manufacture of the same
US5019032A (en) 1990-04-03 1991-05-28 Robertson Jack R Refined suspension procedure with implement for treating female stress incontinence
JPH0724668B2 (en) 1990-05-02 1995-03-22 明夫 山田 Urinary incontinence prevention monitor
EP0459945B1 (en) 1990-05-26 1997-11-19 MED-EL Medical Electronics Elektro-medizinische Geräte GmbH Neuromuscular electrical stimulation device
US5169396A (en) 1990-06-08 1992-12-08 Kambiz Dowlatshahi Method for interstitial laser therapy
US5520606A (en) 1990-10-18 1996-05-28 Schoolman; Arnold Mechanical urinary sphincter device
US5269777A (en) 1990-11-01 1993-12-14 Pdt Systems, Inc. Diffusion tip for optical fibers
US6524274B1 (en) 1990-12-28 2003-02-25 Scimed Life Systems, Inc. Triggered release hydrogel drug delivery system
US5102402A (en) 1991-01-04 1992-04-07 Medtronic, Inc. Releasable coatings on balloon catheters
US6131575A (en) 1991-01-10 2000-10-17 The Procter & Gamble Company Urinary incontinence device
US5199430A (en) 1991-03-11 1993-04-06 Case Western Reserve University Micturitional assist device
US5452719A (en) 1991-07-23 1995-09-26 Eisman; Eugene Multiple electrode myographic probe and method
US5533508A (en) 1991-10-31 1996-07-09 Pdt Systems, Inc. Vivo dosimeter for photodynamic therapy
DE69323779T2 (en) 1991-12-03 1999-09-30 Boston Scientific Ireland Ltd., Saint Michael Instrument for passing a sewing thread
US5439467A (en) 1991-12-03 1995-08-08 Vesica Medical, Inc. Suture passer
US5312439A (en) 1991-12-12 1994-05-17 Loeb Gerald E Implantable device having an electrolytic storage electrode
US5358514A (en) 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes
US5193540A (en) 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US5193539A (en) 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Implantable microstimulator
US5330507A (en) 1992-04-24 1994-07-19 Medtronic, Inc. Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias
EP0680283B1 (en) 1992-04-24 1998-05-13 Surgical Laser Technologies Thermally-resistant medical probe
US5505687A (en) 1992-05-14 1996-04-09 The United States Of America As Represented By The Department Of Health And Human Services Device for measuring incident light in a body cavity
GB9211085D0 (en) 1992-05-23 1992-07-08 Tippey Keith E Electrical stimulation
US5324324A (en) 1992-10-13 1994-06-28 Siemens Pacesetter, Inc. Coated implantable stimulation electrode and lead
US5344439A (en) 1992-10-30 1994-09-06 Medtronic, Inc. Catheter with retractable anchor mechanism
US5807306A (en) 1992-11-09 1998-09-15 Cortrak Medical, Inc. Polymer matrix drug delivery apparatus
US5291902A (en) 1993-01-11 1994-03-08 Brent Carman Incontinence treatment
US5428699A (en) 1993-07-02 1995-06-27 Laserscope Probe having optical fiber for laterally directing laser beam
US5484445A (en) 1993-10-12 1996-01-16 Medtronic, Inc. Sacral lead anchoring system
US5400784A (en) 1993-10-15 1995-03-28 Case Western Reserve University Slowly penetrating inter-fascicular nerve cuff electrode and method of using
US5370670A (en) 1993-12-13 1994-12-06 Thomas Jefferson University Detrusor myoplasty and neuromuscular electrical stimulation of the urinary bladder
US5458595A (en) 1993-12-16 1995-10-17 The Regents Of The University Of California Vaginal speculum for photodynamic therapy and method of using the same
JP2591032Y2 (en) 1993-12-20 1999-02-24 株式会社モリテックス Optical fiber laser light guide diffuser probe
US5518504A (en) 1993-12-28 1996-05-21 American Medical Systems, Inc. Implantable sphincter system utilizing lifting means
US5411016A (en) 1994-02-22 1995-05-02 Scimed Life Systems, Inc. Intravascular balloon catheter for use in combination with an angioscope
DK0676218T3 (en) 1994-03-25 2002-10-07 Novartis Ag Light diffuses and methods of making them
US5423329A (en) 1994-04-15 1995-06-13 Rehab Centers Of America, Inc. Method of treatment for urinary incontinence
EP1217101B8 (en) 1994-04-29 2006-02-01 Boston Scientific Scimed, Inc. Stent with collagen
US5417226A (en) 1994-06-09 1995-05-23 Juma; Saad Female anti-incontinence device
US5733277A (en) 1994-06-22 1998-03-31 Pallarito; Allan L. Optical fibre and laser for removal of arterial or vascular obstructions
US5603685A (en) 1994-07-01 1997-02-18 Tutrone, Jr.; Donald F. Inflatable vaginal pessary
US5431647A (en) 1994-07-13 1995-07-11 Pioneer Optics Company Fiberoptic cylindrical diffuser
US5593405A (en) 1994-07-16 1997-01-14 Osypka; Peter Fiber optic endoscope
US5571148A (en) 1994-08-10 1996-11-05 Loeb; Gerald E. Implantable multichannel stimulator
US5899909A (en) 1994-08-30 1999-05-04 Medscand Medical Ab Surgical instrument for treating female urinary incontinence
SE506164C2 (en) 1995-10-09 1997-11-17 Medscand Medical Ab Instruments for the treatment of urinary incontinence in women
US5833595A (en) 1994-09-06 1998-11-10 Lin; Vernon Wen-Hau Treatment of excretory problems
US6270492B1 (en) 1994-09-09 2001-08-07 Cardiofocus, Inc. Phototherapeutic apparatus with diffusive tip assembly
US6572609B1 (en) 1999-07-14 2003-06-03 Cardiofocus, Inc. Phototherapeutic waveguide apparatus
US6423055B1 (en) 1999-07-14 2002-07-23 Cardiofocus, Inc. Phototherapeutic wave guide apparatus
US5569351A (en) 1994-11-14 1996-10-29 Cms Gilbreth Packaging Systems, Inc. Banding machine having improved film registration system
US5591217A (en) 1995-01-04 1997-01-07 Plexus, Inc. Implantable stimulator with replenishable, high value capacitive power source and method therefor
NL9500495A (en) 1995-03-13 1996-10-01 Cordis Europ Balloon catheter with a single lumen and assembly of such a catheter and a light guide.
NL9500516A (en) 1995-03-15 1996-10-01 Cordis Europ Balloon catheter with light-guiding basic body.
DK46595A (en) 1995-04-21 1996-10-22 Multicept Aps Vibrator
US5824005A (en) 1995-08-22 1998-10-20 Board Of Regents, The University Of Texas System Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias
US5947958A (en) 1995-09-14 1999-09-07 Conceptus, Inc. Radiation-transmitting sheath and methods for its use
CA2229620A1 (en) 1995-11-24 1997-05-29 Advanced Bionics Corporation System and method for conditioning pelvic musculature using an implanted microstimulator
US5658327A (en) * 1995-12-19 1997-08-19 Ventritex, Inc. Intracardiac lead having a compliant fixation device
US5891136A (en) 1996-01-19 1999-04-06 Ep Technologies, Inc. Expandable-collapsible mesh electrode structures
GB9601383D0 (en) 1996-01-24 1996-03-27 Lenadora Shantha J B Device for genuine stress incontinence in the female
DE69725484T2 (en) 1996-02-15 2004-07-15 Nihon Kohden Corp. Device for the treatment of urinary incontinence
US6051017A (en) 1996-02-20 2000-04-18 Advanced Bionics Corporation Implantable microstimulator and systems employing the same
US5728092A (en) 1996-03-07 1998-03-17 Miravant Systems, Inc. Light delivery catheter
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US6013053A (en) 1996-05-17 2000-01-11 Qlt Photo Therapeutics Inc. Balloon catheter for photodynamic therapy
US6146409A (en) 1996-05-20 2000-11-14 Bergein F. Overholt Therapeutic methods and devices for irradiating columnar environments
US5876426A (en) 1996-06-13 1999-03-02 Scimed Life Systems, Inc. System and method of providing a blood-free interface for intravascular light delivery
US5854422A (en) 1996-07-10 1998-12-29 K-Line Industries, Inc. Ultrasonic detector
US5957920A (en) 1997-08-28 1999-09-28 Isothermix, Inc. Medical instruments and techniques for treatment of urinary incontinence
AU4107297A (en) 1996-09-05 1998-03-26 Governors Of The University Of Alberta, The Gastro-intestinal electrical pacemaker
JP2002515793A (en) 1996-10-23 2002-05-28 オーレイテック インターヴェンションズ インコーポレイテッド Method and apparatus for treating an intervertebral disc
EP0846474B1 (en) 1996-10-30 2003-08-27 Nihon Kohden Corporation Stimulating apparatus for preventing urinary incontinence
US5911720A (en) 1996-11-26 1999-06-15 Ep Technologies, Inc. Ablation catheter with segmented tip
US6026326A (en) 1997-01-13 2000-02-15 Medtronic, Inc. Apparatus and method for treating chronic constipation
AU6329598A (en) 1997-02-13 1998-09-08 Boston Scientific Ireland Limited, Barbados Head Office Stabilization sling for use in minimally invasive pelvic surgery
US6208894B1 (en) 1997-02-26 2001-03-27 Alfred E. Mann Foundation For Scientific Research And Advanced Bionics System of implantable devices for monitoring and/or affecting body parameters
WO1998037926A1 (en) 1997-02-26 1998-09-03 Alfred E. Mann Foundation For Scientific Research Battery-powered patient implantable device
US5957965A (en) 1997-03-03 1999-09-28 Medtronic, Inc. Sacral medical electrical lead
US6039686A (en) 1997-03-18 2000-03-21 Kovac; S. Robert System and a method for the long term cure of recurrent urinary female incontinence
US5954761A (en) 1997-03-25 1999-09-21 Intermedics Inc. Implantable endocardial lead assembly having a stent
US5766222A (en) 1997-07-07 1998-06-16 Petit; Michael G. Nipple illuminator for photodynamic therapy
US6135945A (en) 1997-08-04 2000-10-24 Sultan; Hashem Anti-incontinence device
US5824027A (en) 1997-08-14 1998-10-20 Simon Fraser University Nerve cuff having one or more isolated chambers
US6096030A (en) 1997-09-23 2000-08-01 Pharmacyclics, Inc. Light delivery catheter and PDT treatment method
US7628795B2 (en) 1997-09-24 2009-12-08 Atrium Medical Corporation Tunneling device for use with a graft
US6149636A (en) 1998-06-29 2000-11-21 The Procter & Gamble Company Disposable article having proactive sensors
US6104955A (en) 1997-12-15 2000-08-15 Medtronic, Inc. Method and apparatus for electrical stimulation of the gastrointestinal tract
US6212434B1 (en) 1998-07-22 2001-04-03 Cardiac Pacemakers, Inc. Single pass lead system
US6501994B1 (en) 1997-12-24 2002-12-31 Cardiac Pacemakers, Inc. High impedance electrode tip
US6141594A (en) 1998-07-22 2000-10-31 Cardiac Pacemakers, Inc. Single pass lead and system with active and passive fixation elements
US5997571A (en) 1997-12-17 1999-12-07 Cardiofocus, Inc. Non-occluding phototherapy probe stabilizers
US6299609B1 (en) 1998-01-07 2001-10-09 Vasca, Inc. Methods and apparatus for inhibiting infection of subcutaneously implanted devices
US6321116B1 (en) 1998-02-08 2001-11-20 Seung Kee Mo Electrical apparatus medical treatment using EMG envelope signal
US5931864A (en) 1998-02-20 1999-08-03 Cardiac Pacemakers, Inc. Coronary venous lead having fixation mechanism
US6382214B1 (en) 1998-04-24 2002-05-07 American Medical Systems, Inc. Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele
US20050255039A1 (en) 1998-06-26 2005-11-17 Pro Surg, Inc., A California Corporation Gel injection treatment of breast, fibroids & endometrial ablation
WO2000000082A1 (en) 1998-06-29 2000-01-06 The Procter & Gamble Company Disposable article having proactive sensor
US6941171B2 (en) 1998-07-06 2005-09-06 Advanced Bionics Corporation Implantable stimulator methods for treatment of incontinence and pain
US6735474B1 (en) 1998-07-06 2004-05-11 Advanced Bionics Corporation Implantable stimulator system and method for treatment of incontinence and pain
US6027456A (en) 1998-07-10 2000-02-22 Advanced Neuromodulation Systems, Inc. Apparatus and method for positioning spinal cord stimulation leads
US6104960A (en) 1998-07-13 2000-08-15 Medtronic, Inc. System and method for providing medical electrical stimulation to a portion of the nervous system
US6002964A (en) 1998-07-15 1999-12-14 Feler; Claudio A. Epidural nerve root stimulation
US6042536A (en) 1998-08-13 2000-03-28 Contimed, Inc. Bladder sling
US6240316B1 (en) 1998-08-14 2001-05-29 Advanced Bionics Corporation Implantable microstimulation system for treatment of sleep apnea
IL127481A (en) 1998-10-06 2004-05-12 Bio Control Medical Ltd Incontinence treatment device
WO2000019939A1 (en) 1998-10-06 2000-04-13 Bio Control Medical, Ltd. Control of urge incontinence
US6505074B2 (en) 1998-10-26 2003-01-07 Birinder R. Boveja Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator
US6366814B1 (en) 1998-10-26 2002-04-02 Birinder R. Boveja External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
US6356788B2 (en) 1998-10-26 2002-03-12 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy for depression, migraine, neuropsychiatric disorders, partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6964643B2 (en) 1998-11-18 2005-11-15 Nugyn, Inc. Devices and methods for treatment of incontinence
IT1305062B1 (en) 1998-12-23 2001-04-10 Leonardo Cammilli SINGLE INTRODUCTION CATHETER FOR MULTISITE STIMULATION OF THE FOUR CARDIAC CHAMBERS FOR TREATMENT OF PATHOLOGIES SUCH AS
US6161029A (en) 1999-03-08 2000-12-12 Medtronic, Inc. Apparatus and method for fixing electrodes in a blood vessel
US6304786B1 (en) 1999-03-29 2001-10-16 Cardiac Pacemakers, Inc. Implantable lead with dissolvable coating for improved fixation and extraction
US20010025192A1 (en) 1999-04-29 2001-09-27 Medtronic, Inc. Single and multi-polar implantable lead for sacral nerve electrical stimulation
US6055456A (en) 1999-04-29 2000-04-25 Medtronic, Inc. Single and multi-polar implantable lead for sacral nerve electrical stimulation
US6341236B1 (en) 1999-04-30 2002-01-22 Ivan Osorio Vagal nerve stimulation techniques for treatment of epileptic seizures
US6398778B1 (en) 1999-06-18 2002-06-04 Photonics Research Ontario Optical fiber diffuser
AUPQ202699A0 (en) 1999-08-04 1999-08-26 University Of Melbourne, The Prosthetic device for incontinence
US20030028232A1 (en) 2000-01-20 2003-02-06 Medtronic, Inc. Method of lmplanting a medical electrical lead
GB2359256B (en) 2000-01-21 2004-03-03 Sofradim Production Percutaneous device for treating urinary stress incontinence in women using a sub-urethral tape
US7079882B1 (en) 2000-01-22 2006-07-18 Richard Schmidt Method and apparatus for quantifying nerve and neural-muscular integrity related to pelvic organs or pelvic floor functions
US6582441B1 (en) 2000-02-24 2003-06-24 Advanced Bionics Corporation Surgical insertion tool
US6650943B1 (en) 2000-04-07 2003-11-18 Advanced Bionics Corporation Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction
US6616653B2 (en) 2000-04-14 2003-09-09 American Medical Systems, Inc. Method and apparatus for coagulation of superficial blood vessels in bladder and proximal urethra
JP4503208B2 (en) 2000-04-25 2010-07-14 インプレス メディカル, インコーポレイテッド Method and apparatus for generating adhesions in the uterus
US6796972B1 (en) 2000-07-14 2004-09-28 Edwards Lifesciences Llc Catheter anchoring balloon structure with irrigation
US6829411B2 (en) 2000-09-01 2004-12-07 Syntec, Inc. Wide angle light diffusing optical fiber tip
EP1326675B1 (en) 2000-09-07 2011-04-13 Mann Medical Research Organization Apparatus for control of bowel function
US6418930B1 (en) 2000-11-14 2002-07-16 Mayo Foundation For Medical Education And Research Anatomic incontinence pessary
US6971393B1 (en) 2000-11-15 2005-12-06 George Mamo Minimally invasive method for implanting a sacral stimulation lead
KR20030068153A (en) 2000-11-20 2003-08-19 에디컨인코포레이티드 Surgical instrument and method for treating female urinary incontinence
US20020128670A1 (en) 2000-11-22 2002-09-12 Ulf Ulmsten Surgical instrument and method for treating female urinary incontinence
US6986764B2 (en) 2000-12-15 2006-01-17 Laserscope Method and system for photoselective vaporization of the prostate, and other tissue
US20020161382A1 (en) 2001-03-29 2002-10-31 Neisz Johann J. Implant inserted without bone anchors
US7070556B2 (en) 2002-03-07 2006-07-04 Ams Research Corporation Transobturator surgical articles and methods
US6612977B2 (en) 2001-01-23 2003-09-02 American Medical Systems Inc. Sling delivery system and method of use
US6641525B2 (en) 2001-01-23 2003-11-04 Ams Research Corporation Sling assembly with secure and convenient attachment
US6802807B2 (en) 2001-01-23 2004-10-12 American Medical Systems, Inc. Surgical instrument and method
US6952613B2 (en) * 2001-01-31 2005-10-04 Medtronic, Inc. Implantable gastrointestinal lead with active fixation
US6522806B1 (en) 2001-02-16 2003-02-18 Ethicon Endo-Surgury, Inc. Optical fiber including a diffuser portion and continuous sleeve for the transmission of light
EP1372780A4 (en) 2001-03-30 2006-06-14 Univ Case Western Reserve Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses
US6706004B2 (en) 2001-05-31 2004-03-16 Infraredx, Inc. Balloon catheter
SE0102312D0 (en) 2001-06-28 2001-06-28 Obtech Medical Ag Urinary dysfunction treatment apparatus
AU2002316732A1 (en) 2001-07-20 2003-03-03 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Method and apparatus for the treatment of urinary tract dysfunction
US6738674B2 (en) 2001-07-25 2004-05-18 Oscor Inc. Implantable coronary sinus lead with mapping capabilities
US7407480B2 (en) 2001-07-27 2008-08-05 Ams Research Corporation Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele
US6600956B2 (en) 2001-08-21 2003-07-29 Cyberonics, Inc. Circumneural electrode assembly
US6999819B2 (en) 2001-08-31 2006-02-14 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US6745079B2 (en) 2001-11-07 2004-06-01 Medtronic, Inc. Electrical tissue stimulation apparatus and method
US6712772B2 (en) 2001-11-29 2004-03-30 Biocontrol Medical Ltd. Low power consumption implantable pressure sensor
US6862480B2 (en) 2001-11-29 2005-03-01 Biocontrol Medical Ltd. Pelvic disorder treatment device
EP1461117A4 (en) 2001-11-29 2011-03-16 Ams Res Corp Pelvic disorder treatment device
US6899706B2 (en) 2002-01-09 2005-05-31 Inolase 2002 Ltd. Isotopic laser for the oral cavity and use of the same
US6911003B2 (en) 2002-03-07 2005-06-28 Ams Research Corporation Transobturator surgical articles and methods
US20030199961A1 (en) 2002-04-03 2003-10-23 Bjorklund Vicki L. Method and apparatus for fixating a pacing lead of an implantable medical device
US6964699B1 (en) 2002-06-05 2005-11-15 The United States Of America As Represented By The Secretary Of The Navy Rocket motor exhaust scrubber
US7292890B2 (en) 2002-06-20 2007-11-06 Advanced Bionics Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US7860570B2 (en) 2002-06-20 2010-12-28 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US7203548B2 (en) 2002-06-20 2007-04-10 Advanced Bionics Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US20040015205A1 (en) 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US7131963B1 (en) 2002-06-27 2006-11-07 Advanced Cardiovascular Systems, Inc. Catheters and methods of using catheters
ES2554762T3 (en) 2002-06-28 2015-12-23 Boston Scientific Neuromodulation Corporation Microstimulator that has autonomous power supply and directional telemetry system
US20040242956A1 (en) 2002-07-29 2004-12-02 Scorvo Sean K. System for controlling fluid in a body
US7328068B2 (en) 2003-03-31 2008-02-05 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
US20040068203A1 (en) 2002-10-03 2004-04-08 Scimed Life Systems, Inc. Sensing pressure
FR2847169B1 (en) 2002-11-20 2005-02-18 Vygon DEVICE FOR LOCOREGIONAL ANESTHESIA AND METHOD FOR MANUFACTURING THE CANNULA OF THE DEVICE
US7771345B1 (en) 2002-12-03 2010-08-10 O'donnell Pat D Surgical instrument for treating female urinary stress incontinence
US6847848B2 (en) 2003-01-07 2005-01-25 Mmtc, Inc Inflatable balloon catheter structural designs and methods for treating diseased tissue of a patient
US7112195B2 (en) 2003-04-21 2006-09-26 Cynosure, Inc. Esophageal lesion treatment method
US20040248979A1 (en) 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US20050038489A1 (en) 2003-08-14 2005-02-17 Grill Warren M. Electrode array for use in medical stimulation and methods thereof
US7303525B2 (en) 2003-08-22 2007-12-04 Ams Research Corporation Surgical article and methods for treating female urinary incontinence
US7343202B2 (en) 2004-02-12 2008-03-11 Ndi Medical, Llc. Method for affecting urinary function with electrode implantation in adipose tissue
US7347812B2 (en) 2003-09-22 2008-03-25 Ams Research Corporation Prolapse repair
US7135034B2 (en) 2003-11-14 2006-11-14 Lumerx, Inc. Flexible array
US8024050B2 (en) 2003-12-24 2011-09-20 Cardiac Pacemakers, Inc. Lead for stimulating the baroreceptors in the pulmonary artery
US8751003B2 (en) 2004-02-11 2014-06-10 Ethicon, Inc. Conductive mesh for neurostimulation
US8086318B2 (en) 2004-02-12 2011-12-27 Ndi Medical, Llc Portable assemblies, systems, and methods for providing functional or therapeutic neurostimulation
US8467875B2 (en) 2004-02-12 2013-06-18 Medtronic, Inc. Stimulation of dorsal genital nerves to treat urologic dysfunctions
WO2005079295A2 (en) 2004-02-12 2005-09-01 Ndi Medical, Llc Portable assemblies, systems and methods for providing functional or therapeutic neuromuscular stimulation
US20080132969A1 (en) 2004-02-12 2008-06-05 Ndi Medical, Inc. Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat urologic dysfunctions
US7120499B2 (en) 2004-02-12 2006-10-10 Ndi Medical, Llc Portable percutaneous assemblies, systems and methods for providing highly selective functional or therapeutic neuromuscular stimulation
WO2005099809A1 (en) 2004-04-09 2005-10-27 Cook Vascular Incorporated Modular hemostatic valve
US7351197B2 (en) 2004-05-07 2008-04-01 Ams Research Corporation Method and apparatus for cystocele repair
US7500945B2 (en) 2004-04-30 2009-03-10 Ams Research Corporation Method and apparatus for treating pelvic organ prolapse
US20080071321A1 (en) 2004-06-10 2008-03-20 Ndi Medical, Inc. Systems and methods of neuromodulation stimulation for the restoration of sexual function
AU2005254016A1 (en) 2004-06-10 2005-12-29 Ndi Medical, Llc Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence
EP1819394A1 (en) 2004-11-08 2007-08-22 Continence Control Systems International PTY Ltd. An implantable electrode arrangement
US7433739B1 (en) 2004-11-30 2008-10-07 Pacesetter, Inc. Passive fixation mechanism for epicardial sensing and stimulation lead placed through pericardial access
US7914437B2 (en) 2005-02-04 2011-03-29 Ams Research Corporation Transobturator methods for installing sling to treat incontinence, and related devices
US20060241733A1 (en) 2005-04-25 2006-10-26 Cardiac Pacemakers, Inc. Atrial pacing lead
EP1885438A4 (en) 2005-05-13 2013-01-16 Ndi Medical Inc Systems for electrical stimulation of nerves in adipose tissue regions
US20070043416A1 (en) 2005-08-19 2007-02-22 Cardiac Pacemakers, Inc. Implantable electrode array
US20070100411A1 (en) 2005-10-27 2007-05-03 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US7809443B2 (en) 2006-01-31 2010-10-05 Medtronic, Inc. Electrical stimulation to alleviate chronic pelvic pain
EP1991133B1 (en) 2006-02-16 2018-10-24 Boston Scientific Scimed, Inc. Surgical articles for treating pelvic conditions
US8195296B2 (en) 2006-03-03 2012-06-05 Ams Research Corporation Apparatus for treating stress and urge incontinence
US20100318098A1 (en) 2006-04-04 2010-12-16 Lund Robert E Systems and Methods for Implanting Medical Devices
US20090157091A1 (en) 2006-04-04 2009-06-18 Ams Research Corporation Apparatus for Implanting Neural Stimulation Leads
US20070255333A1 (en) 2006-04-28 2007-11-01 Medtronic, Inc. Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
US20070253997A1 (en) 2006-04-28 2007-11-01 Medtronic, Inc. Drug delivery to alleviate chronic pelvic pain
US8219202B2 (en) 2006-04-28 2012-07-10 Medtronic, Inc. Electrical stimulation of ilioinguinal nerve to alleviate chronic pelvic pain
US20070253998A1 (en) 2006-04-28 2007-11-01 Medtronic, Inc. Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain
US20070265675A1 (en) 2006-05-09 2007-11-15 Ams Research Corporation Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation
US8052731B2 (en) 2006-06-02 2011-11-08 Cardiac Pacemakers, Inc. Medical electrical lead with expandable fixation features
EP2032203B1 (en) 2006-06-05 2013-10-23 AMS Research Corporation Electrical muscle stimulation to treat fecal incontinence and/or pelvic prolapse
US7725197B2 (en) 2006-06-15 2010-05-25 Cardiac Pacemakers, Inc. Medical electrical lead with friction-enhancing fixation features
US20090012592A1 (en) 2006-07-10 2009-01-08 Ams Research Corporation Tissue anchor
US8160710B2 (en) 2006-07-10 2012-04-17 Ams Research Corporation Systems and methods for implanting tissue stimulation electrodes in the pelvic region
US20080039828A1 (en) 2006-08-10 2008-02-14 Jimenez Jose W Laser Tissue Vaporization
US7647113B2 (en) 2006-12-21 2010-01-12 Ams Research Corporation Electrode implantation in male external urinary sphincter
US7949409B2 (en) * 2007-01-30 2011-05-24 Cardiac Pacemakers, Inc. Dual spiral lead configurations
US20090259280A1 (en) 2007-10-15 2009-10-15 Kevin Wilkin Electrical stimulation lead with bioerodible anchors and anchor straps
US8019443B2 (en) 2008-04-01 2011-09-13 Boston Scientific Neuromodulation Corporation Anchoring units for leads of implantable electric stimulation systems and methods of making and using
ATE531420T1 (en) 2009-04-28 2011-11-15 Sorin Crm Sas INTRACARDIAL SENSOR FOR STIMULATION OR DEFIBRILLATION WITH RETRACTABLE SCREW
US20100298757A1 (en) 2009-05-19 2010-11-25 Ams Research Corporation Adjuvant enhanced ablation
US8936592B2 (en) 2010-06-03 2015-01-20 Ams Research Corporation Laser tissue ablation system
US8876804B2 (en) 2010-12-17 2014-11-04 Ams Research Corporation Ablation device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4257428A (en) * 1977-12-09 1981-03-24 Barton Steven A Retractable stimulation electrode apparatus and method
US20020151948A1 (en) * 1998-04-30 2002-10-17 Medtronic, Inc. Apparatus and method for expanding a simulation lead body in situ
US20070050003A1 (en) * 2005-08-30 2007-03-01 Cardiac Pacemakers, Inc. Device on lead to prevent perforation and/or fixate lead
US20100049289A1 (en) * 2007-07-10 2010-02-25 Ams Research Corporation Tissue anchor

Also Published As

Publication number Publication date
US20120316627A1 (en) 2012-12-13
US9220887B2 (en) 2015-12-29

Similar Documents

Publication Publication Date Title
US9889292B2 (en) Deployable electrode lead anchor
US20160089531A1 (en) Electrode lead including a deployable tissue anchor
US8301265B2 (en) Selective depth electrode deployment for electrical stimulation
US6704605B2 (en) Medical electrode assembly
US8634932B1 (en) Minimally invasive methods for implanting a sacral stimulation lead
US10369354B2 (en) Systems and method for anchoring a lead for neurostimulation of a target anatomy
EP2408515B1 (en) Implantable device and tissue anchor
US8204569B2 (en) Implantable medical electrical stimulation lead fixation method and apparatus
US7822484B1 (en) MRI-compatible implantable lead having high impedance electrodes
US20070288077A1 (en) Self-anchoring electrical lead with multiple electrodes
US8200343B2 (en) Implantable medical electrical stimulation lead fixation method and apparatus
US8682451B2 (en) Lead system having a non-stationary to stationary electrical interconnect and method therefor
JP2007505699A (en) Fixing medical electrical leads
CN111741789A (en) Neural stimulation leads for testing neural stimulation and methods of use
US20070255367A1 (en) Implantable Medical Electrical Stimulation Lead Fixation Method and Apparatus
US9192317B2 (en) Implantable active fixation lead with biodegradable helical tip
EP3389763B1 (en) Electrical stimulation cuff devices and systems
WO2009094315A2 (en) Medical electrical lead
WO2007146060A2 (en) Self-anchoring electrical lead with multiple electrodes
US8442649B2 (en) Systems and methods for anchoring leads of electrical stimulation systems in and around bony structures
WO2013025678A1 (en) Electrode lead tissue anchor
US20240216675A1 (en) Lead for the temporary stimulation of a peripheral nerve
WO2007047411A2 (en) Systems and devices for stimulating an organ wall

Legal Events

Date Code Title Description
AS Assignment

Owner name: AMS RESEARCH, LLC, MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:AMS RESEARCH CORPATION;REEL/FRAME:037300/0607

Effective date: 20141217

AS Assignment

Owner name: ASTORA WOMEN'S HEALTH, LLC, MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:APHRODITE WOMEN'S HEALTH, LLC;REEL/FRAME:037473/0535

Effective date: 20150929

Owner name: APHRODITE WOMEN'S HEALTH, LLC, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMS RESEARCH, LLC;REEL/FRAME:037473/0425

Effective date: 20150227

Owner name: AMS RESEARCH, LLC, MINNESOTA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:037514/0402

Effective date: 20141217

AS Assignment

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE, DELAWARE

Free format text: SECURITY INTEREST;ASSIGNOR:ASTORA WOMEN'S HEALTH, LLC;REEL/FRAME:042743/0278

Effective date: 20170427

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE

Free format text: SECURITY INTEREST;ASSIGNOR:ASTORA WOMEN'S HEALTH, LLC;REEL/FRAME:042743/0278

Effective date: 20170427

AS Assignment

Owner name: BOSTON SCIENTIFIC CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ASTORA WOMEN'S HEALTH, LLC;ENDO HEALTH SOLUTIONS INC.;ASTORA WOMEN'S HEALTH HOLDINGS, LLC;REEL/FRAME:043777/0895

Effective date: 20161222

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC CORPORATION;REEL/FRAME:043778/0167

Effective date: 20161222

AS Assignment

Owner name: AMS RESEARCH CORPORATION, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FINLAY, MATTHEW S.;RISSMANN, WILLIAM J.;SIGNING DATES FROM 20120606 TO 20120612;REEL/FRAME:044628/0742

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE

AS Assignment

Owner name: VINTAGE PHARMACEUTICALS, LLC, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: SLATE PHARMACEUTICALS, LLC, PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: QUARTZ SPECIALTY PHARMACEUTICALS, LLC, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC), NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: PAR PHARMACEUTICAL, INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: GENERICS INTERNATIONAL (US), INC., NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: GENERICS BIDCO I, LLC, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.), PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: ENDO PHARMACEUTICALS INC., PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.), PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: DAVA PHARMACEUTICALS, LLC, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: DAVA INTERNATIONAL, LLC, PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: BIOSPECIFICS TECHNOLOGIES LLC, PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: BIOSPECIFICS TECHNOLOGIES CORP., PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: AUXILIUM US HOLDINGS, LLC, PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: AUXILIUM PHARMACEUTICALS, LLC, PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: ASTORA WOMEN'S HEALTH LLC, PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: ASTORA WOMEN'S HEALTH HOLDINGS, LLC, MINNESOTA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423

Owner name: ACTIENT PHARMACEUTICALS LLC, PENNSYLVANIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001

Effective date: 20240423